With the analysis among 228 patents, we discovered top 16 key players by total patent application. Oryzon Genomics SA, Takeda Pharmaceutical Co., Ltd., Incyte Corp. are dominant in this area. They take 25.00% of the total patent filing.
Tokyo-to, Japan
Patent: 20
Delaware, United States
Patent: 12
California, United States
Patent: 6
New Jersey, United States
Patent: 5
Australian Capital Territory, Australia
Patent: 4
Shanghai Shi, China
Patent: 1
Hebei Sheng, China
Patent: 1
No data, please try another search term
With the analysis among related 81 patents applied in the last 5 years. We discover 20 most active companies in this area. The fast-growing Shenyang Pharmaceutical University, Incyte Corp., Celgene Corp. take 20.99% of patent filing during this period.
Liaoning Sheng, China
Patent: 6
Delaware, United States
Patent: 6
New Jersey, United States
Patent: 5
Australian Capital Territory, Australia
Patent: 4
Hiroshima-ken, Japan
Patent: 3
South Australia, Australia
Patent: 2
Washington, United States
Patent: 2
With the analysis among related 81 patents in last 5 years, we discover 15 new entrants. Shenyang Pharmaceutical University, Celgene Corp., Chugai Pharmaceutical Co., Ltd. are the most active new entrants in this area.
Liaoning Sheng, China
Patent: 6
New Jersey, United States
Patent: 5
Australian Capital Territory, Australia
Patent: 4
Hiroshima-ken, Japan
Patent: 3
South Australia, Australia
Patent: 2
Beijing Shi, China
Patent: 1
With the analysis among 80 patents, we discovered top 16 universities and scientific research institutions by total patent application. The Johns Hopkins University, University of Washington, Shenyang Pharmaceutical University are dominant in this area. They take 57.50% of the total patent filing.
Washington, United States
Patent: 10
Liaoning Sheng, China
Patent: 6
Shanghai Shi, China
Patent: 4
Hiroshima-ken, Japan
Patent: 3
Nordrhein-Westfalen, Germany
Patent: 2
Utah, United States
Patent: 1
Taiwan Province, China
Patent: 1
Beijing Shi, China
Patent: 1